A subgroup analysis of patients with moderately to severely active Crohn’s disease showed greater clinical and endoscopic ...

P HOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...

For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall costs than beginning with conventional treatments and escalating later.

Inflammatory bowel disease (IBD) is a chronic condition that causes inflammation in the digestive system. It affects about 10 ...

Upadacitinib is now approved for IBD patients unsuitable for TNF blockers after one systemic therapy, broadening treatment options. Clinical trials show upadacitinib's efficacy in achieving remission ...

Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and ...

Find yourself tossing and turning at night? Pacing when you should be sleeping? You might want to keep an eye on your Restless Leg Syndrome (RLS). Research out of South Korea suggests that there may ...

Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the brain's vasculature—the network of blood vessels that supplies it with oxygen and ...

Increased intake of two fermentable fibers, inulin and beta-glucan, was associated with a significantly reduced risk of developing Crohn’s disease (CD) among first-degree relatives of patients with ...